VS38: a New Monoclonal Antibody for Detecting Plasma Cell Differentiation in Routine Sections J Clin Pathol: First Published As 10.1136/Jcp.47.5.418 on 1 May 1994

Total Page:16

File Type:pdf, Size:1020Kb

VS38: a New Monoclonal Antibody for Detecting Plasma Cell Differentiation in Routine Sections J Clin Pathol: First Published As 10.1136/Jcp.47.5.418 on 1 May 1994 4181 JClin Pathol 1994;47:418-422 VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections J Clin Pathol: first published as 10.1136/jcp.47.5.418 on 1 May 1994. Downloaded from H Turley, M Jones, W Erber, K Mayne, M de Waele, K Gatter Abstract mouse monoclonal antibody, VS38, that is Aims-To characterise a new mouse reactive with an antigen expressed strongly on monoclonal antibody, VS38, which recog- normal and neoplastic plasma cells but is nises an intracytoplasmic antigen of 64 absent from haemopoietic cells of other lin- kilodaltons present in normal and neo- eages. This antigen is also expressed to some plastic plasma cells; and to establish its extent in both normal and neoplastic epithe- value as a diagnostic reagent for routine lial cells. VS38 was tested on a wide range of pathological practice. normal and neoplastic tissues including solid Methods-A range of normal and neo- tumours as well as blood and bone marrow plastic tissue sections, both frozen and specimens, with the aim of establishing its routinely fixed, were immunostained, value as a diagnostic reagent for pathological using the microwave method of antigen practice. retrieval for routinely fixed specimens. The antibody was also tested on blood and bone marrow specimens and a range Methods of human cell lines. The molecular PRODUCTION OF ANTIBODY VS38 weight of the antigen recognised by the The source of antigen was a membrane prepa- antibody was obtained by western blot ration of MCF-7 AdR cells. About 4 x 1O' analysis. FACS analysis was used to cells were injected intraperitoneally into a demonstrate the cellular location of the Balb/c mouse, together with Freund's com- antigen and its presence on tonsil cell plete adjuvant. Eleven days later, the mouse suspensions and myeloma cases. was given a booster injection of 1 6 x 106 cells, Results-VS38 recognised normal and with non-complete adjuvant. The booster was neoplastic plasma cells in all of the repeated again seven days later. Three days all tissues, including routinely fixed after the last injection the mouse was killed http://jcp.bmj.com/ plasma cell neoplasms tested. The anti- and the spleen removed. Cell suspensions body also weakly stained epithelial ele- were prepared from the spleen and were fused ments within the tissue but was absent with cells from the myeloma cell line NSIs, from haemopoietic cells of other using polyethylene glycol to induce cell lineages. fusion, as described by Mason and Conclusion-Antibody VS38 is of poten- colleagues.7 tial value in identifying myeloma or on September 27, 2021 by guest. Protected copyright. plasmacytoma in bone marrow or other BIOCHEMICAL ANALYSIS OF THE VS38 EPITOPE tissues. It differentiates lymphoplasma- Cell cultures were washed twice with phos- cytoid lymphoma from lymphocytic and phate buffered saline (PBS) and then har- follicular lymphoma. It also subdivides vested with 0 25% trypsin and 0 02% EDTA. large cell lymphomas into two groups The cell suspension was washed in culture University which may be a more reliable method medium and centrifuged for five minutes at Department of of separating these tumours than mor- 1000 and The cells were Cellular Science, John rpm 4°C. washed Radcliffe Hospital, phology alone. twice in PBS and centrifuged for a final spin Headington, Oxford at 2000 rpm for 10 minutes at 4°C. The cell OX3 9DU (J Clin Pathol 1994;47:418-422) pellet was solubilised with an equal volume of H Turley M Jones 1% (v/v) Triton X-100 (Sigma) in 10 mM K Gatter TRIS-HCL (pH 8) for 20 minutes on ice. K Mayne The terminal stage of B cell differentiation is This was then spun at 2000 rpm for 15 min- Haematology the plasma cell for which no unique antigens utes at 4°C and the supernatant fluid col- Department, Royal have been Perth Hospital, Perth, yet described. Apart from their lected. This was either used immediately for Australia morphology, plasma cells are usually distin- analysis by polyacrylamide gel electrophoresis W Erber guished from other B cells by their lack of sur- (PAGE), or stored as a membrane extract at Laboratorium face HLA class I and class II antigens, surface - 700C. Hematologie et immunoglobulin, Fc and C3 receptors, and Immunologie, Academisch the presence of intracytoplasmic immuno- SDS-PAGE Ziekenhuis, VUB globulin.' Most antibodies which stain plasma Sodium dodecyl sulphate (SDS) polyacry- Brussels, Belgium cells label other B cells as well as cells of other lamide gel electrophoresis was performed on M de Waele lineages.2 6 Most do not work on routinely the extract, according to the method of Correspondence to: Dr Kevin Gatter fixed material, thus further limiting their Laemmli.8 Samples were suspended in buffer Accepted for publication usefulness to pathologists. containing DL-dithiothreitol (Sigma) and 25 November 1993 We describe the characterisation of a boiled for two minutes, allowed to cool, and Plasma cell detection in routine sections 419 loaded on to a gel (5 5% stacking gel, 6-5% were then fixed in acetone/methanol (1 in 1) running gel). Molecular weight markers for 60 seconds at room temperature, placed (Sigma UK) were run at the same time. into TBS (05M TRIS, pH7-6, diluted 1 in 10 Proteins were transferred electrophoreti- in 0- 15M saline) and either stained using the J Clin Pathol: first published as 10.1136/jcp.47.5.418 on 1 May 1994. Downloaded from cally using a Transblot (Biorad UK) appara- alkaline phosphatase-antialkaline phosphatase tus to nitrocellulose membranes9 and the (APAAP) technique, or stored wrapped in protein detected by applying the antibody, aluminium foil at - 20°C until required. They followed by a rabbit-anti-mouse peroxidase were then allowed to reach room temperature conjugate (Dako UK) and visualised using before fixation, as described. diaminobenzidine with metal ion enhance- ment.'0 IMMUNOCYTOCHEMICAL STAINING The APAAP staining technique was per- TISSUES formed, as described before.'2 The enzyme A representative range of normal and neo- reaction was developed using napthol-AS- plastic tissues, including bone marrow biopsy MX-phosphate and fast red (TR-Salt, Sigma specimens, was obtained from the Histo- Chemical Co) as substrate. For immunoper- pathology Department at the John Radcliffe oxidase labelling tissue sections were incu- Hospital. Tissues were immediately snap bated first with the monoclonal antibody for frozen in liquid nitrogen and stored at 30 minutes, then with peroxidase conjugated - 70°C. Cryostat sections (5-8 ,um) were rabbit-anti-mouse (Dakopatts), and finally then cut and collected on to glass multiwell with peroxidase conjugated swine-anti-rabbit slides and dried overnight at room tempera- immunoglobulin."3 The peroxidase reaction ture. The slides were then fixed in acetone at was developed using diaminobenzidine room temperature. The sections were either (Sigma Chemical Co). The slides were then stained immediately or stored wrapped in alu- washed and mounted in aqueous mountant minium foil at - 20°C until staining. (Apathy's; BDH Poole, Dorset). Formalin fixed, paraffin wax embedded sec- tions were cut at approximately 5 pm and FACS ANALYSIS floated on to silane coated glass slides. These White cells and mononuclear cells were iso- were dewaxed, rehydrated, and microwaved lated from peripheral blood and bone marrow in a 700 Watt microwave for 8 minutes in aspirates by red cell lysis using ammonium 0-01 M sodium citrate, then into buffer before chloride'4 or density centrifugation on staining as normal." Lymphoprep (Nygaard, Oslo). The peripheral blood cells were permeabilised using buffered CELL LINES formol acetone (BFA), as described by The following cell lines were obtained from Slaper-Cortenbach et al.'5 After washing in A B C the Sir William Dunn School of Pathology, phosphate buffered saline (PBS) containing http://jcp.bmj.com/ Oxford: K562 (erythroleukaemia); HeLa 0-1% bovine serum albumin (BSA), perme- (cervical epithelial carcinoma); U937 (malig- abilised cells were incubated for 30 minutes at 205 - nant histiocytosis); HL60 (promyelocytic 4°C with the antibodies. Cells were then leukaemia); RVH421 (melanoma); A431 washed and incubated for 30 minutes with (vulval carcinoma); Daudi and Raji (Burkitt's fluorescein isothiocyanate (FITC) conjugated 116 - lymphoma); Nalm-1 (pre-B cell leukaemia); rabbit-anti-mouse F(ab')2 immunoglobulin 97 and Jurkat (T cell lymphoma). The cell lines (Dakopatts a/s). After a final wash the cells on September 27, 2021 by guest. Protected copyright. L428 (Hodgkin's disease) and Thiel (plasma were fixed in 1-5% formaldehyde in washing 68 - cell) were obtained from Dr V Diehl; SU- buffer and analysed in a FACScan flow DHL-1 (T cell leukaemia) from Dr ML cytometer (Becton Dickinson) using Consort Cleary; Karpas 299 (T cell lymphoma with a 30 and Paint-a-Gate software. 2:5 translocation) and Karpas M (plasma cell) from Dr A Karpas; and HT29 (colon carci- noma), MCF 7 ADR (breast carcinoma) from Results the Imperial Cancer Research Fund, London. BIOCHEMICAL ANALYSIS OF EPITOPE The plasma cell lines L363, JJN3, Karpas A strong band of molecular weight 64 kilodal- 29 707, OPM-1, and EJM were obtained from tons (reduced) was detected by VS38 from Professor K Nilsson, University of Uppsala, extracts of the cell lines Thiel (plasma cell Sweden. LB 84-4 (plasma cell), ARH 77 derived), MCF-7, and MCF-7 ADR (breast Figure 1 Western blot (plasma cell), and 8226 R10 (plasma cell) carcinoma derived) (fig 1). Occasionally a analysis of lysatesfrom were from Professor Brian GM Durie. All cell higher molecular weight band of 73 kilodal- three cell lin Lane A M(Ces. (breast lines were cultured in RPMI containing 10% tons was detected in the MCF-7 ADR cell carcinoma) ;F-7 fetal calf serum (Gibco Biocult Ltd) at 37°C.
Recommended publications
  • Plasma Cells: Finding New Light at the End of B Cell Development Kathryn L
    © 2001 Nature Publishing Group http://immunol.nature.com REVIEW Plasma cells: finding new light at the end of B cell development Kathryn L. Calame Plasma cells are cellular factories devoted entire- Upon plasma cell differentiation, there is a marked increase in ly to the manufacture and export of a single prod- steady-state amounts of Ig heavy and light chain mRNA and, when 2 uct: soluble immunoglobulin (Ig). As the final required for IgM and IgA secretion, J chain mRNA . Whether the increase in Ig mRNA is due to increased transcription, increased mediators of a humoral response, plasma cells mRNA stability or, as seems likely, both mechanisms, remains con- play a critical role in adaptive immunity.Although troversial2. There is also an increase in secreted versus membrane intense effort has been devoted to studying the forms of heavy chain mRNA, as determined by differential use of poly(A) sites that may involve the availability of one component of regulation and requirements for early B cell the polyadenylation machinery, cleavage-stimulation factor Cst-643. development, little information has been avail- To accommodate translation and secretion of the abundant Ig able on plasma cells. However, more recent mRNAs, plasma cells have an increased cytoplasmic to nuclear ratio work—including studies on genetically altered and prominent amounts of rough endoplasmic reticulum and secreto- ry vacuoles. mice and data from microarray analyses—has Numerous B cell–specific surface proteins are down-regulated begun to identify the regulatory cascades that upon plasma cell differentiation, including major histocompatibility initiate and maintain the plasma cell phenotype. complex (MHC) class II, B220, CD19, CD21 and CD22.
    [Show full text]
  • REVIEW Multiple Myeloma: the Cells of Origin – a Two-Way Street
    Leukemia (1998) 12, 121–127 1998 Stockton Press All rights reserved 0887-6924/98 $12.00 REVIEW Multiple myeloma: the cells of origin – A two-way street JR Berenson, RA Vescio and J Said West Los Angeles VA Medical Center, UCLA School of Medicine, Los Angeles, CA, USA Multiple myeloma results from an interplay between the mono- earlier precursor cells may be responsible for the proliferation clonal malignant plasma cells and supporting nonmalignant of the malignant population. The presence of a circulating cells in the bone marrow. Recent studies suggest that the final transforming event in this B cell disorder occurs at a late stage tumor component without obvious plasma cell morphology of B cell differentiation based on the characteristics of the also suggests that less mature lymphocytes may be part of the immunoglobulin genes expressed by the malignant clone as clone as well, which could explain the dissemination of the well as surface markers present on the tumor cells. Recently, disease throughout the bone marrow.4 In addition, evidence an increasing pathogenic role in this malignancy by the nonma- for tumor cells at even earlier stages of hematopoietic differen- lignant cells in the bone marrow has been suggested by several tiation came from studies showing the high rate of acute non- studies. Specific infection of these supporting cells by the lymphoblastic leukemia in these patients and the presence of recently identified Kaposi’s sarcoma-associated herpes virus 5,6 (KSHV) suggests a novel mechanism by which this nonmalig- non-lymphoid surface markers on malignant plasma cells. A nant population may lead to the development of this B cell variety of molecular biological techniques have subsequently malignancy and support its growth.
    [Show full text]
  • Restoring Natural Killer Cell Immunity Against Multiple Myeloma in the Era of New Drugs
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Institutional Research Information System University of Turin Restoring Natural Killer Cell immunity against Multiple Myeloma in the era of New Drugs Gianfranco Pittari1, Luca Vago2,3, Moreno Festuccia4,5, Chiara Bonini6,7, Deena Mudawi1, Luisa Giaccone4,5 and Benedetto Bruno4,5* 1 Department of Medical Oncology, National Center for Cancer Care and Research, HMC, Doha, Qatar, 2 Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy, 3 Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy, 4 Department of Oncology/Hematology, A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy, 5 Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy, 6 Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milano, Italy, 7 Vita-Salute San Raffaele University, Milano, Italy Transformed plasma cells in multiple myeloma (MM) are susceptible to natural killer (NK) cell-mediated killing via engagement of tumor ligands for NK activating receptors or “missing-self” recognition. Similar to other cancers, MM targets may elude NK cell immunosurveillance by reprogramming tumor microenvironment and editing cell surface antigen repertoire. Along disease continuum, these effects collectively result in a pro- gressive decline of NK cell immunity, a phenomenon increasingly recognized as a critical determinant of MM progression. In recent years, unprecedented efforts in drug devel- opment and experimental research have brought about emergence of novel therapeutic interventions with the potential to override MM-induced NK cell immunosuppression.
    [Show full text]
  • B-Cell Development, Activation, and Differentiation
    B-Cell Development, Activation, and Differentiation Sarah Holstein, MD, PhD Nov 13, 2014 Lymphoid tissues • Primary – Bone marrow – Thymus • Secondary – Lymph nodes – Spleen – Tonsils – Lymphoid tissue within GI and respiratory tracts Overview of B cell development • B cells are generated in the bone marrow • Takes 1-2 weeks to develop from hematopoietic stem cells to mature B cells • Sequence of expression of cell surface receptor and adhesion molecules which allows for differentiation of B cells, proliferation at various stages, and movement within the bone marrow microenvironment • Immature B cell leaves the bone marrow and undergoes further differentiation • Immune system must create a repertoire of receptors capable of recognizing a large array of antigens while at the same time eliminating self-reactive B cells Overview of B cell development • Early B cell development constitutes the steps that lead to B cell commitment and expression of surface immunoglobulin, production of mature B cells • Mature B cells leave the bone marrow and migrate to secondary lymphoid tissues • B cells then interact with exogenous antigen and/or T helper cells = antigen- dependent phase Overview of B cells Hematopoiesis • Hematopoietic stem cells (HSCs) source of all blood cells • Blood-forming cells first found in the yolk sac (primarily primitive rbc production) • HSCs arise in distal aorta ~3-4 weeks • HSCs migrate to the liver (primary site of hematopoiesis after 6 wks gestation) • Bone marrow hematopoiesis starts ~5 months of gestation Role of bone
    [Show full text]
  • Distribution in Trout Immune Tissues Plasmablast and Plasma Cell
    The Journal of Immunology Plasmablast and Plasma Cell Production and Distribution in Trout Immune Tissues1 Erin S. Bromage,* Ilsa M. Kaattari,* Patty Zwollo,† and Stephen L. Kaattari2* These studies describe the in vitro and ex vivo generation of plasmablasts and plasma cells in trout (Oncorhynchus mykiss) peripheral blood and splenic and anterior kidney tissues. Cells were derived either from naive trout and cultured with the polyclonal activator, Escherichia coli LPS, or from trout that had been immunized with trinitrophenyl-keyhole limpet hemocyanin. Hydroxyurea was used to resolve populations of replicating (plasmablast) and nonreplicating (plasma cell) Ab-secreting cells (ASC). Complete inhibition of Ig secretion was only observed within the PBL. Both anterior kidney and splenic lymphocytes possessed a subset of ASCs that were hydroxyurea resistant. Thus, in vitro production of plasma cells appears to be restricted to the latter two tissues, whereas peripheral blood is exclusively restricted to the production of plasmablasts. After immunization with trinitrophenyl-keyhole limpet hemocyanin, specific ASC could be isolated from all immune organs; however, the anterior kidney contained 98% of all ASC. Late in the response (>10 wk), anterior kidney ASC secreted specific Ab for at least 15 days in culture, indicating that they were long-lived plasma cells. Cells from spleen and peripheral blood lost all capacity to secrete specific Ab in the absence of Ag. Late in the Ab response, high serum titer levels are solely the result of Ig secretion from anterior kidney plasma cells. The Journal of Immunology, 2004, 173: 7317–7323. he immune system of the trout and other teleosts exhibits Plasma cells may become long-lived upon migration to a sup- two striking anatomical differences from mammals: 1) portive niche within the bone marrow, relying on specialized cues T they possess neither bone marrow nor lymph nodes; and for their longevity (14).
    [Show full text]
  • B Cell Responses: Plasmablasts Walk the Line
    RESEARCH HIGHLIGHTS B CELL RESPONSES Plasmablasts walk the line During an adaptive immune patterns in lymph nodes. Following molecule intercellular adhesion response, long-lived antibody- immunization with specific antigen, molecule 1 (ICAM1) in plasmablast producing plasma cells are generated YFP+ cells mainly aggregated in migration. Both YFP+ and naive in T cell-dependent germinal centres. the medulla of the lymph node but B cells migrated on ICAM1-coated Plasma cells subsequently localize to could also be found in the B and glass surfaces, but only naive B cells the lymph node medullary chords, T cell zones and at the border of required Gαi-signalling for this move- but their migration to these sites has germinal centres. By contrast, naive ment. In addition, naive B cells and never been directly observed. A study B cells were predominantly localized plasma blasts had different migratory in Immunity has now reported in B cell follicles. behaviour on the ICAM1-coated sur- unique migratory behaviour for their When the migratory patterns faces; naive B cells showed frequent precursors, plasmablasts; these cells of the different populations were detachment and reattachment to the traverse the lymph node in a linear observed in situ using time-lapse substrate, but YFP+ cells migrated in manner and, surprisingly, do not two-photon intravital microscopy, a steady, amoeboid manner. + require Gαi-coupled receptor YFP cells in the medullary chords Interestingly, in assays carried signalling to migrate. were found to be mainly stationary, out in vivo and in vitro, the authors The transcriptional repressor but YFP+ cells in the follicles were reported an inverse correlation B lymphocyte-induced maturation highly motile.
    [Show full text]
  • Lymphoid System IUSM – 2016
    Lab 14 – Lymphoid System IUSM – 2016 I. Introduction Lymphoid System II. Learning Objectives III. Keywords IV. Slides A. Thymus 1. General Structure 2. Cortex 3. Medulla B. Lymph Nodes 1. General Structures 2. Cortex 3. Paracortex 4. Medulla C. MALT 1. Tonsils 2. BALT 3. GALT a. Peyer’s patches b. Vermiform appendix D. Spleen 1. General Structure 2. White Pulp 3. Red Pulp V. Summary SEM of an activated macrophage. Lab 14 – Lymphoid System IUSM – 2016 I. Introduction Introduction II. Learning Objectives III. Keywords 1. The main function of the immune system is to protect the body against aberrancy: IV. Slides either foreign pathogens (e.g., bacteria, viruses, and parasites) or abnormal host cells (e.g., cancerous cells). A. Thymus 1. General Structure 2. The lymphoid system includes all cells, tissues, and organs in the body that contain 2. Cortex aggregates (accumulations) of lymphocytes (a category of leukocytes including B-cells, 3. Medulla T-cells, and natural-killer cells); while the functions of the different types of B. Lymph Nodes lymphocytes vary greatly, they generally all appear morphologically similar so cannot be 1. General Structures routinely distinguished in light microscopy. 2. Cortex 3. Lymphocytes can be found distributed throughout the lymphoid system as: (1) single 3. Paracortex cells, (2) isolated aggregates of cells, (3) distinct non-encapsulated lymphoid nodules in 4. Medulla loose CT associated with epithelium, or (4) encapsulated individual lymphoid organs. C. MALT 1. Tonsils 4. Primary lymphoid organs are sites where lymphocytes are formed and mature; they 2. BALT include the bone marrow (B-cells) and thymus (T-cells); secondary lymphoid organs are sites of lymphocyte monitoring and activation; they include lymph nodes, MALT, and 3.
    [Show full text]
  • IL-6 Supports the Generation of Human Long-Lived Plasma Cells in Combination with Either APRIL Or Stromal Cell-Soluble Factors
    Leukemia (2014) 28, 1647–1656 & 2014 Macmillan Publishers Limited All rights reserved 0887-6924/14 www.nature.com/leu ORIGINAL ARTICLE IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors M Jourdan1, M Cren1, N Robert2, K Bollore´ 2, T Fest3,4, C Duperray1,2, F Guilloton4, D Hose5,6,KTarte3,4 and B Klein1,2,7 The recent understanding of plasma cell (PC) biology has been obtained mainly from murine models. The current concept is that plasmablasts home to the BM and further differentiate into long-lived PCs (LLPCs). These LLPCs survive for months in contact with a complex niche comprising stromal cells (SCs) and hematopoietic cells, both producing recruitment and survival factors. Using a multi-step culture system, we show here the possibility to differentiate human memory B cells into LLPCs surviving for at least 4 months in vitro and producing immunoglobulins continuously. A remarkable feature is that IL-6 is mandatory to generate LLPCs in vitro together with either APRIL or soluble factors produced by SCs, unrelated to APRIL/BAFF, SDF-1, or IGF-1. These LLPCs are out of the cell cycle, express highly PC transcription factors and surface markers. This model shows a remarkable robustness of human LLPCs, which can survive and produce highly immunoglobulins for months in vitro without the contact with niche cells, providing the presence of a minimal cocktail of growth factors and nutrients. This model should be useful to understand further normal PC biology and its deregulation in premalignant or malignant PC disorders.
    [Show full text]
  • The Effects of Thymus and Other Lymphoid Organs Enclosed in Millipore Diffusion Chambers on Neonatally Thymectomized Mice* by David Osoba, M.D
    THE EFFECTS OF THYMUS AND OTHER LYMPHOID ORGANS ENCLOSED IN MILLIPORE DIFFUSION CHAMBERS ON NEONATALLY THYMECTOMIZED MICE* BY DAVID OSOBA, M.D. (From the Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada) PLATES 39 XO 42 (Received for publication, April 7, 1965) The possibility that the thymus produces a humoral substance with far reaching biological effects has been frequently considered. Support for the production of a hormone has been offered on morphological grounds by the description of secretory vesicles in the frog thymus (1), and colloid-containing cysts lined by ciliated cuboidal cells in normal mouse thymus (2, 3). Although there have been claims of the discovery of thymus-derived substances exhibiting anticancer properties (4, 5), with growth-promoting or growth-retarding effects (6), and with antibacterial (7) and antiviral activity (8), none of these claims has been widely substantiated. Meanwhile, the possibility that the thymus, e/a a humoral factor, exerts an effect on other lymphoid tissue has been receiving increasing support. Several authors have reported a transient lymphocytosis-stimulating effect following the injection of a variety of thymus extracts in guinea pigs (9) and mice thymec- tomized in adult life (10), in intact neonatal mice (11), and in young rabbits (12) and rats (13). Also, extracts and implants of heavily irradiated thymuses from pigs and rabbits have been found to produce a lymphoid hyperplastic response in the regional lymph nodes of young rats (14). Direct evidence that the thymus produces a humoral factor, which plays a role in the development of immunity, has been provided by the discovery that the deficient immune responses found in mice after neonatal thymectomy can be prevented by intraperitoneally implanted grafts of thymus tissue enclosed within Millipore diffusion chambers (15-19).
    [Show full text]
  • Antigens Cell-Independent Or T Cell-Dependent Induced Early In
    Long-Lived Bone Marrow Plasma Cells Are Induced Early in Response to T Cell-Independent or T Cell-Dependent Antigens This information is current as of October 2, 2021. Alexandra Bortnick, Irene Chernova, William J. Quinn III, Monica Mugnier, Michael P. Cancro and David Allman J Immunol 2012; 188:5389-5396; Prepublished online 23 April 2012; doi: 10.4049/jimmunol.1102808 Downloaded from http://www.jimmunol.org/content/188/11/5389 Supplementary http://www.jimmunol.org/content/suppl/2012/04/24/jimmunol.110280 Material 8.DC1 http://www.jimmunol.org/ References This article cites 48 articles, 23 of which you can access for free at: http://www.jimmunol.org/content/188/11/5389.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on October 2, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Long-Lived Bone Marrow Plasma Cells Are Induced Early in Response to T Cell-Independent or T Cell-Dependent Antigens Alexandra Bortnick,* Irene Chernova,* William J.
    [Show full text]
  • The Bone Marrow As Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology
    cells Review The Bone Marrow as Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology Stefan A. Slamanig 1,2,† and Martijn A. Nolte 1,2,* 1 Department of Molecular Hematology, Sanquin Research, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands; [email protected] 2 Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands * Correspondence: [email protected] † Current address: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Abstract: The bone marrow (BM) is key to protective immunological memory because it harbors a major fraction of the body’s plasma cells, memory CD4+ and memory CD8+ T-cells. Despite its paramount significance for the human immune system, many aspects of how the BM enables decade-long immunity against pathogens are still poorly understood. In this review, we discuss the relationship between BM survival niches and long-lasting humoral immunity, how intrinsic and extrinsic factors define memory cell longevity and show that the BM is also capable of adopting many responsibilities of a secondary lymphoid organ. Additionally, with more and more data on the differentiation and maintenance of memory T-cells and plasma cells upon vaccination in humans being reported, we discuss what factors determine the establishment of long-lasting immunological memory in the BM and what we can learn for vaccination technologies and antigen design. Finally, using these insights, we touch on how this holistic understanding of the BM is necessary for the development of modern and efficient vaccines against the pandemic SARS-CoV-2. Citation: Slamanig, S.A.; Nolte, M.A.
    [Show full text]
  • Single-Cell Sequencing Reveals Clonally Expanded Plasma Cells During Chronic Viral Infection Produce Virus-Specific and Cross-Reactive Antibodies
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.29.428852; this version posted January 31, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Single-cell sequencing reveals clonally expanded plasma cells during chronic viral infection produce virus-specific and cross-reactive antibodies Daniel Neumeier1, Alessandro Pedrioli2 , Alessandro Genovese2, Ioana Sandu2, Roy Ehling1, Kai-Lin Hong1, Chrysa Papadopoulou1, Andreas Agrafiotis1, Raphael Kuhn1, Damiano Robbiani1, Jiami Han1, Laura Hauri1, Lucia Csepregi1, Victor Greiff3, Doron Merkler4,5, Sai T. Reddy1,*, Annette Oxenius2,*, Alexander Yermanos1,2,4,* 1Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland 2Institute of Microbiology, ETH Zurich, Zurich, Switzerland 3Department of Immunology, University of Oslo, Oslo, Norway 4Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland 5Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland *Correspondence: [email protected] ; [email protected] ; [email protected] Graphical abstract. Single-cell sequencing reveals clonally expanded plasma cells during chronic viral infection produce virus-specific and cross-reactive antibodies. bioRxiv preprint doi: https://doi.org/10.1101/2021.01.29.428852; this version posted January 31, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Neumeier et al., Abstract Plasma cells and their secreted antibodies play a central role in the long-term protection against chronic viral infection.
    [Show full text]